Whitty, Jennifer A. http://orcid.org/0000-0002-5886-1933
de Bekker-Grob, Esther W. http://orcid.org/0000-0001-7645-6168
Cook, Nigel S. http://orcid.org/0000-0001-8211-7613
Terris-Prestholt, Fern http://orcid.org/0000-0003-1693-5196
Drummond, Michael
Falchetto, Rocco
Hillege, Hans L.
Article History
First Online: 29 November 2019
Compliance with Ethical Standards
:
: Jennifer A. Whitty is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East of England (NIHR200177). Esther W. de Bekker-Grob is funded through a personal grant from The Netherlands Organisation for Scientific Research (NWO-Talent-Scheme-Veni-Grant No. 451-15-039) and supported by the EU/EFPIA Innovative Medicines Initiative [CitationRef removed] Joint Undertaking PREFER grant no. 115966. Nigel S. Cook is an employee of Novartis Pharma AG and the work presented was funded by Novartis. RF is funded through out-of-pocket private donations to the IPPN. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care.
: Jennifer A. Whitty, Rocco Falchetto, Hans L. Hillege, Fern Terris-Prestholt and Michael Drummond are members of the International Academy of Health Preference Research (IAHPR). Esther W. de Bekker-Grob is a member of IAHPR and IMI-PREFER. Nigel S. Cook is a member of IAHPR and IMI-PREFER and is an employee of Novartis Pharma AG. None of the authors have any conflicts of interest that are directly relevant to the content of this article.